Skip to main content

Table 2 Recurrence after radical resection in the TME and CCRT + TME groups

From: Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial

Variable TME group [cases (%)] CCRT + TME group [cases (%)] P value
Postoperative recurrence 0.971
 Yes 19 (20.2) 18 (20.0)  
 No 75 (79.8) 72 (80.0)  
Recurrence period 0.858
 Early recurrence (≤ 24 months) 10 (52.6) 10 (55.6)  
 Late recurrence (> 24 months) 9 (47.4) 8 (44.4)  
Recurrence patterna
 Local recurrence 4 (4.3) 5 (5.6) 0.743
 Liver metastasis 2 (2.1) 4 (4.4) 0.437
 Lung metastasis 9 (9.6) 7 (7.8) 0.665
 Other site metastasis 4 (4.3) 6 (6.7) 0.530
  1. TME, total mesorectal excision; CCRT, concurrent chemoradiotherapy
  2. aThere were 3 patients developed multiple metastasis